I like the trademark :-)
Interesting...
Andrew J. Rennekamp
@AJRennekamp
New #SARSCoV2 #COVID19 paper just accepted at Cell! Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor. #2019nCoV https://cell.com/2019-nCOV
https://www.cell.com/2019-nCOV
:-)